Challenges in prognostic analysis

Cancer

Volumn 91, Issue 8 SUPPL., 2001, Pages 1607-1614

  Concato, John ^a,b,c  

^a VA Medical Center   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCULATION; CONFERENCE PAPER; DATA ANALYSIS; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL ANALYSIS;

EID: 0035871394     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010415)91:8+<1607::aid-cncr1174>3.0.co;2-j     Document Type: Conference Paper

References (28)

1. Expression of epidermal growth factor receptor and c-erb B-2 (HER-2/neu) oncoprotein in prostatic carcinomas
2. Overexpression of Her-2/neu may be an indicator of poor prognosis in prostate cancer
3. Contribution of HER-2/neu oncogene expression to tumor grade and DNA content analysis in the prediction of prostatic carcinoma metastasis
4. Expression of the c-erbB-2 (HER-2/neu) oncoprotein in human prostatic carcinoma
5. Prognostic significance of HER-2/neu gene amplification status by fluorescence in situ hybridization of prostate carcinoma
6. An analysis of microvessel density, androgen receptor, p53 and HER-2/neu expression and Gleason score in prostate cancer. Preliminary results and therapeutic implications
7. Statistical aspects of prognostic factor studies in oncology
8. Dangers of using "optimal" cutpoints in the evaluation of prognostic factors
9. Clinical biostatistics. XIV. The purposes of prognostic stratification
10. Clinical biostatistics. XV. The process of prognostic stratification. I
11. Clinical biostatistics. XVI. The process of prognostic stratification. II
12. A new clinical-anatomic staging system for evaluating prognosis and treatment of prostatic cancer
13. Prognostic staging system for recurrent, persistent, and second primary cancers of the oral cavity and oropharynx
14. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation
15. Long-term survival among men with conservatively treated localized prostate cancer
16. Importance of functional measures in predicting mortality among older hospitalized patients
17. Observer variability in the histopathologic diagnosis of lung cancer
18. Variability in radiologists' interpretations of mammograms
19. Problems of comorbidity in mortality after prostatectomy
20. The risk of determining risk with multivariable models
21. Assessing the generalizability of prognostic information
22. The Will Rogers phenomenon. State migration and new diagnostic techniques as a source of misleading statistics for survival in cancer
23. Validation of a staging system for evaluating prognosis in prostate cancer